Clinical value of application of new rapid pathological diagnosis technology in ultrasound-guided puncture in thyroid cancer

Objective To explore the clinical value of applying new rapid pathological diagnosis technology in ultrasound-guided puncture in thyroid cancer. Methods Twelve patients taking thyroid puncture who preoperatively tended to have thyroid cancer and were confirmed by postoperative pathology were selected. Among which, 8 cases were examined with US-FNA, and 4 with US-CNB. The new rapid pathological diagnosis technique was used during thyroid puncture operation. Real-time cytology was first diagnosed and the puncture operation plan was adjusted in real time according to the results of rapid pathological diagnosis. The clinical value of new rapid pathological diagnosis technique in thyroid cancer puncture was analyzed. Results The new rapid pathological diagnosis technology required a small space and had no pollution. The diagnosis took about 2 to 3 minutes and did not affect the normal puncture biopsy operation. 2 cases (25.0%) of the 8 taking US-FNAs and 1 case (25.0%) of the 4 taking US-CNBs with the assistance of this technology confirmed the requirement of biopsy quality and quantity. Conclusion Because of various factors, the quality and quantity of biopsy tissue are often not guaranteed in the US-FNA or US-CNB tests. The new rapid pathological diagnosis technology can provide real-time pathological diagnosis during thyroid puncture and improve the quality and quantity of puncture tissue, and ensure the first success rate of thyroid puncture; and the cost of this technology is low; so it is suitable for implementation in hospitals at all levels. Key words: New rapid pathological diagnosis technique; Thyroid cancer; US-FNA; US-CNB; Clinical value